{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:35:28Z","timestamp":1780076128289,"version":"3.54.0"},"reference-count":48,"publisher":"American Association for Cancer Research (AACR)","issue":"12","funder":[{"DOI":"10.13039\/100000869","name":"Susan G. Komen","doi-asserted-by":"publisher","award":["CCR15332379"],"award-info":[{"award-number":["CCR15332379"]}],"id":[{"id":"10.13039\/100000869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","award":["BJFH CFF 3781 & 4035"],"award-info":[{"award-number":["BJFH CFF 3781 & 4035"]}],"id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["P30 CA091842"],"award-info":[{"award-number":["P30 CA091842"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["#P30CA091842"],"award-info":[{"award-number":["#P30CA091842"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The receptor activator of nuclear factor-\u03baB (RANK) pathway plays essential roles in breast development. Mammographic density is a strong risk factor for breast cancer, especially in premenopausal women. We, therefore, investigated the associations of circulating RANK and soluble RANK ligand (sRANKL) with mammographic density in premenopausal women. Mammographic density was measured as volumetric percent density in 365 cancer-free premenopausal women (mean age, 47.5 years) attending screening mammogram at the Washington University School of Medicine (St. Louis, MO). We used linear regression models adjusted for confounders, to compare the least-square means of volumetric percent density across tertiles of circulating RANK and sRANKL. Furthermore, because RANKL levels in mammary tissue are modulated by progesterone, we stratified analyses by progesterone levels. The mean volumetric percent density increased across tertiles of circulating RANK from 8.6% in tertile 1, to 8.8% in tertile 2, and 9.5% in tertile 3 (Ptrend = 0.02). For sRANKL, the mean volumetric percent density was 8.5% in tertile 1, 9.4% in tertile 2, and 9.0% in tertile 3 (Ptrend = 0.30). However, when restricted to women with higher progesterone levels, the mean volumetric percent density increased from 9.1% in sRANKL tertile 1 to 9.5% in tertile 2, and 10.1% in tertile 3 (Ptrend = 0.01). Circulating RANK was positively associated with volumetric percent density, while circulating sRANKL was positively associated with volumetric percent density among women with higher progesterone levels. These findings support the inhibition of RANKL signaling as a pathway to reduce mammographic density and possibly breast cancer incidence in high-risk women with dense breasts.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-18-0199","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T10:57:25Z","timestamp":1540292245000},"page":"789-796","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Circulating Receptor Activator of Nuclear Factor-\u03baB (RANK), RANK ligand (RANKL), and Mammographic Density in Premenopausal Women"],"prefix":"10.1158","volume":"11","author":[{"given":"Adetunji T.","family":"Toriola","sequence":"first","affiliation":[{"name":"1Department of Surgery, Division of Public Health Sciences, and Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Appleton","sequence":"additional","affiliation":[{"name":"2Division of Diagnostic Radiology, Department of Radiology, Washington University School of Medicine, St. Louis, Missouri."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5646-710X","authenticated-orcid":false,"given":"Xiaoyu","family":"Zong","sequence":"additional","affiliation":[{"name":"1Department of Surgery, Division of Public Health Sciences, and Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqin","family":"Luo","sequence":"additional","affiliation":[{"name":"1Department of Surgery, Division of Public Health Sciences, and Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Weilbaecher","sequence":"additional","affiliation":[{"name":"3Division of Oncology, Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, Missouri."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulla M.","family":"Tamimi","sequence":"additional","affiliation":[{"name":"4Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7307-0291","authenticated-orcid":false,"given":"Graham A.","family":"Colditz","sequence":"additional","affiliation":[{"name":"1Department of Surgery, Division of Public Health Sciences, and Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2018,12,10]]},"reference":[{"key":"2022060816484940600_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJMoa062790","article-title":"Mammographic density and the risk and detection of breast cancer","volume":"356","author":"Boyd","year":"2007","journal-title":"N Engl J Med"},{"key":"2022060816484940600_bib2","doi-asserted-by":"crossref","first-page":"pii: dju255","DOI":"10.1093\/jnci\/dju255","article-title":"Prevalence of mammographically dense breasts in the United States","volume":"106","author":"Sprague","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2022060816484940600_bib3","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1158\/0008-5472.CAN-11-3295","article-title":"Mammographic breast density and breast cancer: evidence of a shared genetic basis","volume":"72","author":"Varghese","year":"2012","journal-title":"Cancer Res"},{"key":"2022060816484940600_bib4","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1038\/ncomms6303","article-title":"Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk","volume":"5","author":"Lindstrom","year":"2014","journal-title":"Nat Commun"},{"key":"2022060816484940600_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2014.01.002","article-title":"RANKL\/RANK - from bone physiology to breast cancer","volume":"25","author":"Sigl","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"2022060816484940600_bib6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12094-011-0646-5","article-title":"RANKL inhibition: a promising novel strategy for breast cancer treatment","volume":"13","author":"Gonzalez-Suarez","year":"2011","journal-title":"Clin Transl Oncol"},{"key":"2022060816484940600_bib7","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1515\/bc.2010.149","article-title":"Physiology and pathophysiology of the RANKL\/RANK system","volume":"391","author":"Hanada","year":"2010","journal-title":"Biol Chem"},{"key":"2022060816484940600_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0092-8674(00)00103-3","article-title":"The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development","volume":"103","author":"Fata","year":"2000","journal-title":"Cell"},{"key":"2022060816484940600_bib9","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature09027","article-title":"Control of mammary stem cell function by steroid hormone signalling","volume":"465","author":"Asselin-Labat","year":"2010","journal-title":"Nature"},{"key":"2022060816484940600_bib10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature09091","article-title":"Progesterone induces adult mammary stem cell expansion","volume":"465","author":"Joshi","year":"2010","journal-title":"Nature"},{"key":"2022060816484940600_bib11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature09387","article-title":"Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer","volume":"468","author":"Schramek","year":"2010","journal-title":"Nature"},{"key":"2022060816484940600_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature09495","article-title":"RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis","volume":"468","author":"Gonzalez-Suarez","year":"2010","journal-title":"Nature"},{"key":"2022060816484940600_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/nrendo.2010.202","article-title":"Cancer: RANKL inhibition-a new weapon against breast cancer?","volume":"7","author":"Koch","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"2022060816484940600_bib14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nm.4118","article-title":"RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers","volume":"22","author":"Nolan","year":"2016","journal-title":"Nat Med"},{"key":"2022060816484940600_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1158\/0008-5472.CAN-16-2025","article-title":"Out-RANKing BRCA1 in mutation carriers","volume":"77","author":"Nolan","year":"2017","journal-title":"Cancer Res"},{"key":"2022060816484940600_bib16","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.18632\/oncotarget.14013","article-title":"Aberrant regulation of RANKL\/OPG in women at high risk of developing breast cancer","volume":"8","author":"Kiechl","year":"2017","journal-title":"Oncotarget"},{"key":"2022060816484940600_bib17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1158\/1940-6207.CAPR-17-0125","article-title":"Circulating RANKL and RANKL\/OPG and breast cancer risk by ER and PR subtype: results from the EPIC cohort","volume":"10","author":"Sarink","year":"2017","journal-title":"Cancer Prev Res"},{"key":"2022060816484940600_bib18","doi-asserted-by":"crossref","first-page":"73787","DOI":"10.18632\/oncotarget.17909","article-title":"Increased breast tissue receptor activator of nuclear factor- kappaB ligand (RANKL) gene expression is associated with higher mammographic density in premenopausal women","volume":"8","author":"Toriola","year":"2017","journal-title":"Oncotarget"},{"key":"2022060816484940600_bib19","doi-asserted-by":"crossref","first-page":"pii: dju078","DOI":"10.1093\/jnci\/dju078","article-title":"Mammographic density phenotypes and risk of breast cancer: a meta-analysis","volume":"106","author":"Pettersson","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2022060816484940600_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.imlet.2004.05.010","article-title":"Expression of membrane-bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells","volume":"94","author":"Kanamaru","year":"2004","journal-title":"Immunol Lett"},{"key":"2022060816484940600_bib21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10552-018-1035-y","article-title":"Serum osteoprotegerin levels and mammographic density among high-risk women","volume":"29","author":"Moran","year":"2018","journal-title":"Cancer Causes Control"},{"key":"2022060816484940600_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1158\/1940-6207.CAPR-17-0309","article-title":"Adiposity at age 10 and mammographic density among premenopausal women","volume":"11","author":"Alimujiang","year":"2018","journal-title":"Cancer Prev Res"},{"key":"2022060816484940600_bib23","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.clinbiochem.2014.03.013","article-title":"Placental growth factor, soluble fms-like tyrosine kinase 1 and progesterone as diagnostic biomarkers for ectopic pregnancy and missed abortion","volume":"47","author":"Mart\u00ednez-Ruiz","year":"2014","journal-title":"Clin Biochem"},{"key":"2022060816484940600_bib24","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/ijc.24132","article-title":"Does the increase of endogenous steroid hormone levels also affect breast cancer risk in Chinese women? A case\u2013control study in Chongqing, China","volume":"124","author":"Wang","year":"2009","journal-title":"Int J Cancer"},{"key":"2022060816484940600_bib25","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/0284185114554674","article-title":"Comparison of mammographic density estimation by Volpara software with radiologists' visual assessment: analysis of clinical-radiologic factors affecting discrepancy between them","volume":"56","author":"Lee","year":"2015","journal-title":"Acta Radiol"},{"key":"2022060816484940600_bib26","doi-asserted-by":"crossref","first-page":"e70217","DOI":"10.1371\/journal.pone.0070217","article-title":"Age and ethnic differences in volumetric breast density in new zealand women: a cross-sectional study","volume":"8","author":"Ellison-Loschmann","year":"2013","journal-title":"PLoS One"},{"key":"2022060816484940600_bib27","volume-title":"Volpara density user manual version 1.5","author":"Solutions","year":"2013"},{"key":"2022060816484940600_bib28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: Issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"2022060816484940600_bib29","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10549-015-3496-y","article-title":"Effect of weight loss on bone health in overweight\/obese postmenopausal breast cancer survivors","volume":"152","author":"Toriola","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"2022060816484940600_bib30","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1101\/gad.13.23.3037","article-title":"The genetic transformation of bone biology","volume":"13","author":"Karsenty","year":"1999","journal-title":"Genes Dev"},{"key":"2022060816484940600_bib31","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1128\/MCB.17.7.3629","article-title":"Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth","volume":"17","author":"Nakshatri","year":"1997","journal-title":"Mol Cell Biol"},{"key":"2022060816484940600_bib32","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1242\/dev.088948","article-title":"Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells","volume":"140","author":"Lee","year":"2013","journal-title":"Development"},{"key":"2022060816484940600_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mce.2011.09.030","article-title":"From the ranks of mammary progesterone mediators, RANKL takes the spotlight","volume":"357","author":"Fernandez-Valdivia","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"2022060816484940600_bib34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/bcr452","article-title":"The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis","volume":"4","author":"Anderson","year":"2002","journal-title":"Breast Cancer Res"},{"key":"2022060816484940600_bib35","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"2022060816484940600_bib36","first-page":"4559","article-title":"Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast","volume":"84","author":"Hofseth","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2022060816484940600_bib37","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","article-title":"Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin","volume":"92","author":"Ross","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2022060816484940600_bib38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"2022060816484940600_bib39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.breast.2005.04.014","article-title":"Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women","volume":"15","author":"Noh","year":"2006","journal-title":"Breast"},{"key":"2022060816484940600_bib40","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM199506153322401","article-title":"The use of estrogens and progestins and the risk of breast cancer in postmenopausal women","volume":"332","author":"Colditz","year":"1995","journal-title":"N Engl J Med"},{"key":"2022060816484940600_bib41","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1470-2045(05)70273-4","article-title":"Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment","volume":"6","author":"Cogliano","year":"2005","journal-title":"Lancet Oncol"},{"key":"2022060816484940600_bib42","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/jnci\/dji279","article-title":"Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial","volume":"97","author":"McTiernan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"2022060816484940600_bib43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnci\/95.1.30","article-title":"Postmenopausal hormone therapy and change in mammographic density","volume":"95","author":"Greendale","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"2022060816484940600_bib44","doi-asserted-by":"crossref","first-page":"86687","DOI":"10.18632\/oncotarget.13417","article-title":"Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers","volume":"7","author":"Od\u00e9n","year":"2016","journal-title":"Oncotarget"},{"key":"2022060816484940600_bib45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12916-017-0786-8","article-title":"Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort","volume":"15","author":"Fortner","year":"2017","journal-title":"BMC Med"},{"key":"2022060816484940600_bib46","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jama.291.9.1108","article-title":"Soluble RANKL and risk of nontraumatic fracture","volume":"291","author":"Schett","year":"2004","journal-title":"JAMA"},{"key":"2022060816484940600_bib47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s13058-014-0439-1","article-title":"Digital mammographic density and breast cancer risk: a case-control study of six alternative density assessment methods","volume":"16","author":"Eng","year":"2014","journal-title":"Breast Cancer Res"},{"key":"2022060816484940600_bib48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3348\/kjr.2014.15.3.313","article-title":"Mammographic density estimation with automated volumetric breast density measurement","volume":"15","author":"Ko","year":"2014","journal-title":"Korean J Radiol"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/11\/12\/789\/1934269\/789.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/11\/12\/789\/1934269\/789.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T15:11:16Z","timestamp":1654701076000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/11\/12\/789\/274983\/Circulating-Receptor-Activator-of-Nuclear-Factor-B"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,10]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-18-0199","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.c.6547687","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22534882.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22534882","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6547687.v1","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}